Skip to content

Study on the Effect and Mechanism of Auricular Vagus Nerve Stimulation on Postoperative Cognitive Dysfunction in the Elderly

Study on the Effect and Mechanism of Auricular Vagus Nerve Stimulation on Postoperative Cognitive Dysfunction in the Elderly

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115495
Enrollment
Unknown
Registered
2025-12-26
Start date
2024-05-14
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative neurocognitive disorder

Interventions

the auricular vagal nerve stimulation group:Perioperative auricular vagus nerve stimulation

Sponsors

Jiaxing Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Age >= 65 years; (2) Patients undergoing elective surgery for abdominal malignancy (gastrointestinal tumors); (3) American Society of Anesthesiologists (ASA) Class I-III; (4) Montreal Cognitive Assessment Scale (MoCA) >=23 points.

Exclusion criteria

Exclusion criteria: (1) Have a communication disability (e.g., difficulty in seeing, hearing, speaking); (2) Comorbid or previous central nervous system disorders such as stroke, Alzheimer's disease, and others; (3) Comorbid or former psychosomatic disorders such as depression, mania, anxiety, schizophrenia, and others; (4) Comorbid immune system disorders;Long-term treatment with anti-inflammatory drugs, painkillers, glucocorticoids, and cytotoxic drugs; (5) History of alcoholism, drug abuse, or drug dependence; (6) Skin lesions at the site of electroacupuncture stimulation; (7) Inability to be still during treatment, such as Parkinson's disease, epilepsy, and others; (8) Illiteracy and inability to communicate normally in Chinese. (9) Postoperative hospital stay <7 days.

Design outcomes

Primary

MeasureTime frame
Postoperative cognitive dysfunction;

Secondary

MeasureTime frame
Changes in perioperative plasma S100ß and IL-6;Changes in postoperative sleep quality and postoperative pain intensity;Postoperative nausea and vomiting,Postoperative delirium;

Countries

China

Contacts

Public ContactJian Lu

Jiaxing Second Hospital

ljp200681@163.com+86 139 6730 3968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026